Feb 21 |
Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
|
Feb 20 |
Bicycle Therapeutics GAAP EPS of -$1.16 beats by $0.15, revenue of $5.33M misses by $1.55M
|
Feb 20 |
Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results
|
Feb 13 |
Bicycle Therapeutics gains as former Seagen holder boosts stake
|
Feb 7 |
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Jan 22 |
15 Small-Cap Stocks with High Potential
|
Jan 5 |
Bicycle Therapeutics PLC CEO Kevin Lee Sells 8,703 Shares
|
Dec 22 |
Circling Back On Bicycle Therapeutics
|
Dec 14 |
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs and Strategy Overview at First R&D Day
|
Nov 30 |
Bicycle Therapeutics to Host R&D Day on December 14
|